T Cell Therapy of Opportunistic Cytomegalovirus Infection

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Cytomegalovirus Infections · Hematopoietic Stem Cell Transplant · Opportunistic Infections

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Contact: Study coordinator (Mari H Dallas, MD) · CTUReferral@UHhospitals.org · 1-800-641-2422
Contact: Principal Investigator (Mari H Dallas, MD)

Study leads

Mari H Dallas, MD
Principal Investigator
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Allogeneic Hematopoietic Stem Cell Transplantation Recipient · Cytomegalovirus · Donor

Abroad (travel likely)RecruitingEARLY_PHASE1

Columbus, United States · Columbus, United States

CMV-CMI in csCMVi After HSCT

Cytomegalovirus Infections · Hematopoietic Stem Cell Transplantation (HSCT) · Immune Reconstitution

Abroad (travel likely)Recruiting

Suzhou, China

Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Immunoglobulin Prophylaxis · Cytomegalovirus Infections · Allogeneic Hematopoietic Stem Cell Transplantation

Abroad (travel likely)Recruiting

Trieste, Italy

Evaluation of CMV/EBV-CMI in Haploid HSCT

Hematopoietic Stem Cell Transplantation · Cytomegalovirus Infections · Epstein-Barr Virus Infections

Abroad (travel likely)Recruiting

Suzhou, China